280 related articles for article (PubMed ID: 191476)
1. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
[TBL] [Abstract][Full Text] [Related]
2. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
Miller OV; Gorman RR
J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
[TBL] [Abstract][Full Text] [Related]
3. Platelet prostaglandin production and its implications.
Smith JB; Ingerman CM; Silver MJ
Adv Prostaglandin Thromboxane Res; 1976; 2():747-53. PubMed ID: 983875
[TBL] [Abstract][Full Text] [Related]
4. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
Smith JB; Ingerman CM; Silver MJ
J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
[TBL] [Abstract][Full Text] [Related]
5. Platelet accumulation on collagen: drugs which inhibit arachidonic acid metabolism and affect intracellular cyclic AMP levels.
Adams GA; Feuerstein IA
Thromb Haemost; 1984 Aug; 52(1):45-9. PubMed ID: 6093281
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
Malmsten C; Granström E; Samuelsson B
Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797
[No Abstract] [Full Text] [Related]
7. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
8. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
9. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
[TBL] [Abstract][Full Text] [Related]
10. Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets.
Matsuoka I; Suzuki T
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):341-53. PubMed ID: 6147364
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
13. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
Ardelt W
Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100
[TBL] [Abstract][Full Text] [Related]
14. On the interrelationship of prostaglandin endoperoxide G2 and cyclic nucleotides in platelet function.
Claesson HE; Malmsten C
Eur J Biochem; 1977 Jun; 76(1):277-84. PubMed ID: 195812
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
[TBL] [Abstract][Full Text] [Related]
16. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
Salzman EW
Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
[TBL] [Abstract][Full Text] [Related]
17. The influence of prostaglandin endoperoxides on platelet ultrastructure.
Gerrard JM; White JG
Am J Pathol; 1975 Aug; 80(2):189-202. PubMed ID: 169697
[TBL] [Abstract][Full Text] [Related]
18. The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion.
Gerrard JM; Townsend D; Stoddard S; Witkop CJ; White JG
Am J Pathol; 1977 Jan; 86(1):99-116. PubMed ID: 188341
[TBL] [Abstract][Full Text] [Related]
19. Elevation of the cyclic GMP concentration in human platelets by sodium ascorbate and 5-hydroxytryptamine.
Schoepflin GS; Pickett W; Austen KF; Goetzl EJ
J Cyclic Nucleotide Res; 1977 Oct; 3(5):355-65. PubMed ID: 201683
[TBL] [Abstract][Full Text] [Related]
20. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
